Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

A comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: results of the Early or Late Intervention in unStable Angina (ELISA) pilot study. 2b/3a upstream therapy and acute coronary syndromes.

van 't Hof AW, de Vries ST, Dambrink JH, Miedema K, Suryapranata H, Hoorntje JC, Gosselink AT, Zijlstra F, de Boer MJ.

Eur Heart J. 2003 Aug;24(15):1401-5.

PMID:
12909068
2.

Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial.

van 't Hof AW, Ernst N, de Boer MJ, de Winter R, Boersma E, Bunt T, Petronio S, Marcel Gosselink AT, Jap W, Hollak F, Hoorntje JC, Suryapranata H, Dambrink JH, Zijlstra F; On-TIME study group.

Eur Heart J. 2004 May;25(10):837-46.

PMID:
15140531
3.

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.

Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, Neumann FJ, Robertson DH, DeLucca PT, DiBattiste PM, Gibson CM, Braunwald E; TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy)--Thrombolysis in Myocardial Infarction 18 Investigators.

N Engl J Med. 2001 Jun 21;344(25):1879-87.

6.

Use of glycoprotein IIb/IIIa inhibitors in invasively-treated patients with non-ST elevation acute coronary syndrome.

De Servi S, Mariani M, Vandoni P, Dellavalle A, Politi A, Poletti F, Bonizzoni E, Leoncinie M; Registro Osservazionale Angina Instabile (ROSAI-2) Investigators.

J Cardiovasc Med (Hagerstown). 2006 Mar;7(3):159-65.

PMID:
16645379
8.
10.

Benefit of an early invasive management strategy in women with acute coronary syndromes.

Glaser R, Herrmann HC, Murphy SA, Demopoulos LA, DiBattiste PM, Cannon CP, Braunwald E.

JAMA. 2002 Dec 25;288(24):3124-9.

PMID:
12495392
11.
13.
14.

Effect of platelet glycoprotein IIb/IIIa receptor blockade with tirofiban on adverse cardiac events in women with unstable angina/non-ST-elevation myocardial infarction (PRISM-PLUS Study).

Huynh T, Theroux P, Snapinn S, Wan Y; Montreal General Hospital, Montreal, Quebec, Canada. thao.huynh@muhc.mcgill.ca.

Am Heart J. 2003 Oct;146(4):668-73.

PMID:
14564321
15.

National economic impact of tirofiban for unstable angina and myocardial infarction without ST elevation; example from the United Kingdom.

Bakhai A, Flather MD, Collinson JR, Stevens W, Normand C, Alemao E, Itzler R, Ben-Joseph R.

Int J Cardiol. 2003 Oct;91(2-3):163-72.

PMID:
14559126
16.

Routine upstream versus selective down stream use of tirofiban in non-ST elevation myocardial infarction patients scheduled for early invasive therapy; a randomized comparison.

Rasoul S, Ottervanger JP, de Boer MJ, Dambrink JH, Suryapranata H, Hoorntje JC, Gosselink AT, van 't Hof AW; ELISA study group.

J Thromb Thrombolysis. 2007 Dec;24(3):241-6. Epub 2007 Mar 2.

PMID:
17334935
17.

Combination therapy with tirofiban and enoxaparin in acute coronary syndromes.

Cohen M, Théroux P, Weber S, Laramée P, Huynh T, Borzak S, Diodati JG, Squire IB, Deckelbaum LI, Thornton AR, Harris KE, Sax FL, Lo MW, White HD.

Int J Cardiol. 1999 Dec 1;71(3):273-81.

PMID:
10636535
18.

A comparison of dual vs. triple antiplatelet therapy in patients with non-ST-segment elevation acute coronary syndrome: results of the ELISA-2 trial.

Rasoul S, Ottervanger JP, de Boer MJ, Miedema K, Hoorntje JC, Gosselink M, Zijlstra F, Suryapranata H, Dambrink JH, van 't Hof AW.

Eur Heart J. 2006 Jun;27(12):1401-7. Epub 2006 May 8.

PMID:
16682384
20.

Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial.

Blazing MA, de Lemos JA, White HD, Fox KA, Verheugt FW, Ardissino D, DiBattiste PM, Palmisano J, Bilheimer DW, Snapinn SM, Ramsey KE, Gardner LH, Hasselblad V, Pfeffer MA, Lewis EF, Braunwald E, Califf RM; 'A to Z' Investigators.

JAMA. 2004 Jul 7;292(1):55-64. Erratum in: JAMA. 2004 Sep 8;292(10):1178. Dosage error in article text.

PMID:
15238591

Supplemental Content

Support Center